Expression of adhesion molecules and extracellular matrix proteins in glioblastomas: Relation to angiogenesis and spread

Histopathology

Volumn 28, Issue 6, 1996, Pages 521-528

  Vitolo, D ^a   Paradiso, P ^a   Uccini, S ^a   Ruco, L P ^a   Baroni, C D ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Cattedra di Igiene   (Italy)

Author keywords

Adhesion molecules; Extracellular matrix proteins; Glioblastoma

Indexed keywords

CADHERIN; CD31 ANTIGEN; CD68 ANTIGEN; CELL ADHESION MOLECULE; GLIAL FIBRILLARY ACIDIC PROTEIN; INTEGRIN; MEROSIN; TENASCIN; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL;

EID: 0029931595     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1996.d01-471.x     Document Type: Article

References (43)

1. Kleihues P, Burger PC, Scheithauer BW. Histological typing of Tumours of the Central Nervous System. World Health Organization. International Histological Classification of Tumours, Berlin: Springer-Verlag, Heidelberg, 1993.
2. Russel DS, Rubinstein LJ. Tumors of neuroepithelial origin in Pathology of Tumours of the Nervous System, 5th edn. London: Edward Arnold, 1989; 83-350.
3. Burger PC, Kleihues P. Cytologic composition of the untreated glioblastoma with implications for evaluation of needle biopsies. Cancer 1989; 63; 2014-2023.
4. Zülch KJ. Histological typing of tumors of the central nervous system. International histological classification of tumours Geneva: World Health Organization, 1979; 21; 1-56.
5. Burger PC, Vogel FS, Green SB, Strike AT. Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer 1985; 56; 1106-1111.
6. Weller RO. Tumours of the nervous system. In Symmers SC ed. Systemic Pathology, 3rd edn. Edinburgh: Churchill Livingston, 1990; 4; 427-503.
7. 1 integrin. J. Cell. Biol. 1991; 113; 417-428.
8. Paulus W, Baur I, Schuppan D, Roggendorf W. Characterization of integrin receptors in normal and neoplastic human brain. Am. J. Pathol. 1993; 143; 154-163.
9. Freedman AS, Munro JM, Rice GE et al. Adhesion of human B cells to germinal centres in vitro involves VLA-4 and INCAM-110. Science 1990; 249; 1030-1033.
10. Smith MEF, Thomas JA. Cellular expression of lymphocyte function associated antigens and intercellular adhesion molecule-1 in normal tissue. J. Clin. Pathol. 1990; 43; 893-900.
11. Bronner-Fraser M. An antibody to a receptor for fibronectin and laminin perturbs cranial neural crest development in vivo. Dev. Biol. 1986; 117; 528-536.
12. Couldwell WT, de Tribolet N, Antel JP, Gauthier T, Kuppner MC. Adhesion molecules and malignant gliomas: implications for tumorigenesis. J. Neurosurg. 1992; 76; 782-791.
13. Baroni CD, Vitolo D, Remotti D et al. Immunohistochemical heterogeneity of macrophage subpopulations in human lymphoid tissues. Histopathology 1987; 11; 1029-1042.
14. Janzer RC, Raff MC. Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 1987; 325; 253-257.
15. Zagzag D, Miller DC, Sato Y, Rifkin DB, Burstein DE. Immunohistochemical localization of basic fibroblast growth factor in astrocytomas. Cancer Res. 1990; 50; 7393-7398.
16. Brem S, Tsanaclis AMC, Gately S, Gross JL, Herblin WF. Immunolocalization of basic fibroblast growth factor to the microvasculature of human brain tumors. Cancer 1992; 70; 2673-2680.
17. Takashashi JA, Fukumoto M, Igarashi K, Oda Y, Kikuchi H, Hatanaka M. Correlation of basic fibroblast growth factor expression levels with the degree of malignancy and vascularity in human gliomas. J. Neurosurg. 1992; 76; 792-798.
18. Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992; 359; 845-848.
19. Kim KJ, Li B, Winer J et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 1993; 362; 841-844.
20. Mapstone TB. Expression of platelet-derived growth factor and transforming growth factor and their correlation with cellular morphology in glial tumors. J. Neurosurg. 1991; 75; 447-451.
21. Clark WC, Bressler J. Transforming growth factor-β-Like activity in tumors of the central nervous system. J. Neurosurg. 1988; 68; 920-924.
22. Lampugnani MG, Resnati M, Raiteri M et al. A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J. Cell. Biol. 1992; 118; 1511-1522.
23. Adams Pearson C, Pearson D, Shibahara S, Hofsteenge J, Chiquet-Ehrismann R. Tenascin: cDNA cloning and induction by TGF-β. EMBO J. 1988; 10; 2677-2981.
24. Zagzag D. Angiogenic growth factors in neural embriogenesis and neoplasia. Am. J. Pathol. 1995; 146; 293-309.
25. 3 integrins. J. Cell Sci. 1993; 105; 1001-1012.
26. Liotta LA, Stetler-Stevenson WG, Steeg PS. Cancer invasion and metastasis: positive and negative regulatory elements. Cancer Invest. 1991; 9; 543-551.
27. Zagzag D, Brem S, Robert F. Neovascularization and tumor growth in the rabbit brain: a model for experimental studies of angiogenesis and the blood-brain barrier. Am. J. Pathol. 1988; 131; 361-372.
28. Belldegrun A, Kassid A, Uppenkamp M, Topalian SL, Rosenberg SA. Human tumor infiltrating lymphocytes. Analysis of lymphokine mRNA expression and relevance to cancer immunotherapy. J. Immunol. 1989; 142; 4520-4526.
29. Vitolo D, Letessier EM, Johnson JT, Whiteside TL. Immunologic effector cells in head and neck cancer. JNCI Monogr. 1992; 13; 203-208.
30. Vitolo D, Zerbe T, Kanbour A, Dahl C, Herberman RB, Whiteside TL. Expression of mRNA for cytokines in tumor-infiltrating mononuclear cells in ovarian adenocardnoma and invasive breast cancer. Int. J. Cancer 1992; 51; 573-580.
31. Vitolo D, Palmieri MB, Marzullo A, Ruco LP, Baroni CD. Adhesion molecules and lymphocyte recruitment in lymphocytic thyroiditis, thyroid papillary carcinoma and parotid adenolymphoma. Path. Res. Pract. 1994; 190; 999-1004.
32. Vitolo D, Palmieri MB, Ruco LP, Rendina E, Bonsignore G, Baroni CD. Cytokine production and expression of adhesion molecules and integrins in tumor infiltrating lymphomononuclear cells of non-small cell carcinomas of the lung. Am. J. Pathol. 1994; 145; 322-329.
33. Whiteside TL, Jost LM, Herbermann RB. Tumor infiltrating lymphocytes. Potential and limitations to their use for cancer therapy Crit. Rev. Oncol. Hematol. 1992; 20; 25-47.
34. Kradin RL, Bhan AK. Tumor Infiltrating Lymphocytes. Lab. Invest. 1993; 69; 635-638.
35. Pober JS. Cytokine-mediated activation of vascular endothelium: physiology and pathology. Am. J. Pathol. 1987; 133; 426-433.
36. Pardi R, Invelardi L, Benderr JR. Regulatory mechanisms in leucocyte adhesion: flexible receptors for sophisticated travellers. Immunol. Today 1992; 13; 224-230.
37. Mortarini R, Anichini A, Parmiani C. Heterogeneity for integrin expression and cytokine-mediated VLA modulation can influence the adhesion of human melanoma cells to extracellular matrix proteins. Int. J. Cancer 1991; 47; 551-559.
38. Miettinen M, Castello R, Wayner E, Schwarting R. Distribution of VLA integrins in solid tumors. Emergence of tumor-type-related expression patterns in carcinomas and sarcomas. Am. J. Pathol. 1993; 142; 1009-1018.
39. Fabry Z, Raine CS, Hart MN. Nervous tissue as an immune compartment: the dialect of the immune response in the CNS. Immunol. Today 1994; 15; 218-224.
40. Takamiya Y, Kohsaka S, Toya S, Otani M, Tsukada Y. Immunohistochemical studies on the proliferation of reactive astrocytes and the expression of cytochemical proteins following brain injury in rats. Developmental Brain Research 1988; 466; 201-210.
41. Ruco LP, Stoppacciaro A, Uccini S et al. Expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in undifferentiated nasopharyngeal carcinoma (lymphoepithelioma) and in malignant epithelial tumors. Hum Pathol. 1994; 25; 924-928.
42. Ruco, LP, de Laat, PAJM, Bernasconi, S, Sciacca, FM, van der Kwast, Hoogsteden, HC, Uccini, S, Mantovani, A, Versnel, MA. Expression of ICAM-1 and VCAM-1 in human malignant mesothelioma. J. Pathol. 1996; in press.
43. Elices MJ, Osborn L, Takada Y, Crouse C, Luhowskyi S, Helmer ME. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/ fibronectin binding site. Cell 1990; 60; 577-584.